These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26753210)

  • 1. [Treat-to-target in rheumatology].
    Majdan M
    Wiad Lek; 2015; 68(3):259-64. PubMed ID: 26753210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rheumatoid arthritis treat-to-target trial: a cluster randomized trial within the Corrona rheumatology network.
    Harrold LR; Reed GW; Harrington JT; Barr CJ; Saunders KC; Gibofsky A; Greenberg JD; John A; Devenport J; Kremer JM
    BMC Musculoskelet Disord; 2014 Nov; 15():389. PubMed ID: 25416400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MonitorNet: the Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice.
    Sfriso P; Salaffi F; Montecucco CM; Bombardieri S; Todesco S
    Reumatismo; 2009; 61(2):132-9. PubMed ID: 19633800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Institute of Rheumatology and progress of antirheumatic therapy].
    Sigidin IaA
    Vestn Ross Akad Med Nauk; 1998; (12):7-9. PubMed ID: 9987950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of treat-to-target strategy studies in rheumatic diseases: A systematic review and meta-analysis.
    Hao Y; Oon S; Nikpour M
    Semin Arthritis Rheum; 2024 Aug; 67():152465. PubMed ID: 38796922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [University contribution to implementation of the treat-to-target concept in rheumatology].
    Kalden JR; Müller-Ladner U; Schmidt RE
    Z Rheumatol; 2011 Oct; 70(8):651-5. PubMed ID: 21979316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treat-to-target in rheumatoid arthritis: Evaluating the patient perspective using the Patient Opinion Real-Time Anonymous Liaison system: The RA T2T PORTAL study.
    Benham H; Rutherford M; Kirby S; Stebbings S; White D; Sim D; Harrison A
    Int J Rheum Dis; 2019 May; 22(5):874-879. PubMed ID: 30793870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany.
    Huscher D; Merkesdal S; Thiele K; Zeidler H; Schneider M; Zink A;
    Ann Rheum Dis; 2006 Sep; 65(9):1175-83. PubMed ID: 16540552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rheumatic diseases in pregnancy].
    Märker-Hermann E; Bauer H; Gromnica-Ihle E
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2410-4. PubMed ID: 18988134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treat-to-target (T2T) from the perspective of inpatient rheumatology].
    Lakomek HJ; Krause A
    Z Rheumatol; 2011 Oct; 70(8):656-63. PubMed ID: 21979317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial.
    Hørslev-Petersen K; Hetland ML; Junker P; Pødenphant J; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Horn HC; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Johansen JS; Østergaard M; Stengaard-Pedersen K;
    Ann Rheum Dis; 2014 Apr; 73(4):654-61. PubMed ID: 23434570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leflunomide in Pakistani patients with rheumatoid arthritis: prospective study in daily rheumatology practice.
    Ahmad NM; Farman S; Saeed MA; Hameed R; Umair M; Ghafoor E
    Int J Rheum Dis; 2011 Feb; 14(1):48-54. PubMed ID: 21303481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings of the 5th annual perspectives in rheumatic diseases.
    Furst DE; Mandell B; Calabrese LH; Cather JC; Clauw DJ; Deodhar A; Kremer JM; Lewiecki EM; McMahon M; Ritchlin CT
    Semin Arthritis Rheum; 2013 Dec; 43(3):416-9. PubMed ID: 24326035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chinese expert-based consensus for methotrexate in rheumatic diseases].
    Chinese Association of Rheumatology and Immunology Physicians
    Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):719-722. PubMed ID: 30293331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treat-to-target in systemic lupus erythematosus: are we there yet?
    Mok CC
    Expert Rev Clin Pharmacol; 2016; 9(5):675-80. PubMed ID: 26809011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GISEA: an Italian biological agents registry in rheumatology.
    Lapadula G; Ferraccioli G; Ferri C; Punzi L; Trotta F;
    Reumatismo; 2011 Nov; 63(3):155-64. PubMed ID: 22257916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The National Data Bank for Rheumatic Diseases (NDB).
    Michaud K
    Clin Exp Rheumatol; 2016; 34(5 Suppl 101):S100-S101. PubMed ID: 27762196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network in pediatric rheumatology: the example of pediatric rheumatology international trials organisation.
    Ruperto N; Martini A
    Georgian Med News; 2008 Mar; (156):68-74. PubMed ID: 18403813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study with a new phenylbutazone preparation in rheumatology].
    Marmont A; Rossi F
    Clin Ter; 1972 Oct; 63(1):17-51. PubMed ID: 4566104
    [No Abstract]   [Full Text] [Related]  

  • 20. Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.
    Vermeer M; Kuper HH; Hoekstra M; Haagsma CJ; Posthumus MD; Brus HL; van Riel PL; van de Laar MA
    Arthritis Rheum; 2011 Oct; 63(10):2865-72. PubMed ID: 21647867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.